NEW YORK ( TheStreet) -- The following 10 global pharmaceutical stocks will likely benefit from the expanding global pharmaceutical markets, which are poised to grow at 5%-7% in 2011 to $880 billion, according to IMS Health. 17 Pharmemerging markets, including China and India, are forecast to grow at 15%-17% in 2011 to $180 billion, faster than the global markets.Analysts give these 10 stocks a 100% buy ratings. In comparison, pharma giants Johnson & Johnson (JNJ), Pfizer (PFE), Merck (MRK), Abbott Laboratories (ABT), Bristol Myers Squibb (BMY) and Eli Lilly (LLY) have buy ratings in the range of 8.3%-71.4%.
10 Pharma Stocks With 100% Buy Ratings
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts